✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Q-Line Biotech Ltd.

QLINE

Market Cap
₹1,275 Cr.
P/E
22.88

Q-Line Biotech Ltd.

  • Q-Line Biotech
  • Poly Medicure
  • Tarsons Products

FAQs on Q-Line Biotech Ltd. Shareprice

There is not enough historical data for the companies share price.

Q-Line Biotech is not expensive.
Latest PE of Q-Line Biotech is 22.88, while 3 year average PE is 35.45.
Also latest EV/EBITDA of Q-Line Biotech is 13.32 while 3yr average is 13.69.

View FAQ's On Business

Growth Table

  • Q-Line Biotech Ltd.
  • Poly Medicure
  • Tarsons Products

Balance Sheet

  • Q-Line Biotech Ltd.
  • Poly Medicure
  • Tarsons Products

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Q-Line Biotech Ltd.
  • Poly Medicure
  • Tarsons Products

Cash Flow

  • Q-Line Biotech Ltd.
  • Poly Medicure
  • Tarsons Products

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Q-Line Biotech Ltd.
  • Poly Medicure
  • Tarsons Products

Quarterly Results

  • Q-Line Biotech Ltd.
  • Poly Medicure
  • Tarsons Products

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Q-Line Biotech Ltd. Financials

Balance sheet of Q-Line Biotech is strong.
But short term working capital might become an issue for this company.

Yes, The net debt of Q-Line Biotech is increasing.
Latest net debt of Q-Line Biotech is ₹149 Crs as of Mar-26.
This is greater than Mar-25 when it was ₹72.67 Crs.

The profit is oscillating.
The profit of Q-Line Biotech is ₹0 Crs for Mar 2026, ₹0 Crs for Mar 2025 and ₹0 Crs for Mar 2024

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Q-Line Biotech latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Capital Work in Progress, Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech